Latham M

General

Full name :

First name :

Mail :

Zip Code :

City :

Country :

Email :

Phone :

Fax :

Website :

Directory :

References (2)

Title : A randomized, placebo-controlled clinical trial evaluating the safety and efficacy of the once-weekly DPP-4 inhibitor omarigliptin in patients with type 2 diabetes mellitus inadequately controlled by glimepiride and metformin - Lee_2017_BMC.Endocr.Disord_17_70
Author(s) : Lee SH , Gantz I , Round E , Latham M , O'Neill EA , Ceesay P , Suryawanshi S , Kaufman KD , Engel SS , Lai E
Ref : BMC Endocr Disord , 17 :70 , 2017
Abstract : Lee_2017_BMC.Endocr.Disord_17_70
ESTHER : Lee_2017_BMC.Endocr.Disord_17_70
PubMedSearch : Lee_2017_BMC.Endocr.Disord_17_70
PubMedID: 29110647

Title : Development and validation of a rapid analytical method to quantify naled residue - Zhong_2001_J.Am.Mosq.Control.Assoc_17_225
Author(s) : Zhong H , Latham M
Ref : J Am Mosq Control Assoc , 17 :225 , 2001
Abstract : Zhong_2001_J.Am.Mosq.Control.Assoc_17_225
ESTHER : Zhong_2001_J.Am.Mosq.Control.Assoc_17_225
PubMedSearch : Zhong_2001_J.Am.Mosq.Control.Assoc_17_225
PubMedID: 11804458